Heme and hemoglobin are redox active mediators of oxidative damage in multiple diseases.
Limitations with current methods for free hemoglobin and heme measures are highlighted.
New protocols for measuring free hemoglobin and heme simultaneously based on spectral deconvolution are provided.
Improved accuracy for heme measures in stored red cells and levels higher than reported in Sickle cell disease is shown.